{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:21:53Z","timestamp":1790749313348,"version":"4.1.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T00:00:00Z","timestamp":1328659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0031080","type":"journal-article","created":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T21:45:21Z","timestamp":1328737521000},"page":"e31080","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["Genetic Knock-Down of Hdac3 Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington's Disease"],"prefix":"10.1371","volume":"7","author":[{"given":"Lara","family":"Moumn\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Howland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian P.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,2,8]]},"reference":[{"key":"ref1","article-title":"Huntington&apos;s disease","author":"G Bates","year":"2002"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington&apos;s disease chromosomes. The Huntington&apos;s Disease Collaborative Research Group.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","volume":"277","author":"M DiFiglia","year":"1997","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington&apos;s disease: can mice lead the way to treatment?","volume":"69","author":"ZR Crook","journal-title":"Neuron"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.","volume":"87","author":"L Mangiarini","year":"1996","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.","volume":"90","author":"SW Davies","year":"1997","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington&apos;s disease.","volume":"10","author":"CH Lin","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes.","volume":"72","author":"B Woodman","year":"2007","journal-title":"Brain Res Bull"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington&apos;s disease mutation.","volume":"19","author":"RJ Carter","year":"1999","journal-title":"J Neurosci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington&apos;s disease mutation.","volume":"19","author":"LA Lione","year":"1999","journal-title":"J Neurosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington&apos;s disease transgenic mice.","volume":"490","author":"EC Stack","year":"2005","journal-title":"J Comp Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin&apos;s effects on striatal gene expression in mice recapitulate changes observed in human Huntington&apos;s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.","volume":"16","author":"A Kuhn","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e8025","DOI":"10.1371\/journal.pone.0008025","article-title":"Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington&apos;s disease.","volume":"4","author":"H Moffitt","year":"2009","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/hmg\/ddp467","article-title":"Identical oligomeric and fibrillar structures captured from the brains of R6\/2 and knock-in mouse models of Huntington&apos;s disease.","volume":"19","author":"K Sathasivam","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","article-title":"Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.","volume":"285","author":"C Landles","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington&apos;s disease.","volume":"83","author":"JH Cha","year":"2007","journal-title":"Prog Neurobiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington&apos;s disease models.","volume":"16","author":"G Sadri-Vakili","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H","article-title":"Roles of histone acetyltransferases and deacetylases in gene regulation.","volume":"20","author":"MH Kuo","year":"1998","journal-title":"Bioessays"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.biocel.2008.05.026","article-title":"Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.","volume":"41","author":"R Codd","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.molcel.2005.02.022","article-title":"Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.","volume":"17","author":"JL Avalos","year":"2005","journal-title":"Mol Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1523\/JNEUROSCI.3344-05.2006","article-title":"Differential contributions of Caenorhabditis elegans histone deacetylases to Huntingtin polyglutamine toxicity.","volume":"26","author":"EA Bates","year":"2006","journal-title":"J Neurosci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington&apos;s disease mice.","volume":"23","author":"RJ Ferrante","year":"2003","journal-title":"J Neurosci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington&apos;s disease.","volume":"280","author":"G Gardian","year":"2005","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington&apos;s disease.","volume":"100","author":"E Hockly","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.","volume":"413","author":"JS Steffan","year":"2001","journal-title":"Nature"},{"key":"ref26","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington&apos;s disease transgenic mice.","author":"EA Thomas","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e20696","DOI":"10.1371\/journal.pone.0020696","article-title":"Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6\/2 mouse model of Huntington&apos;s disease.","volume":"6","author":"A Bobrowska","year":"2011","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e5747","DOI":"10.1371\/journal.pone.0005747","article-title":"Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6\/2 mouse model of Huntington&apos;s disease.","volume":"4","author":"CL Benn","year":"2009","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02686117","article-title":"Distribution of histone deacetylases 1\u201311 in the rat brain.","volume":"31","author":"RS Broide","year":"2007","journal-title":"J Mol Neurosci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1073\/pnas.0608659104","article-title":"Activity-based probes for proteomic profiling of histone deacetylase complexes.","volume":"104","author":"CM Salisbury","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington&apos;s disease.","volume":"17","author":"J Pallos","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(01)00429-4","article-title":"Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT\/N-CoR.","volume":"9","author":"W Fischle","year":"2002","journal-title":"Mol Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1074\/jbc.M105993200","article-title":"Functional domains of histone deacetylase-3.","volume":"277","author":"WM Yang","year":"2002","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1128\/MCB.21.18.6091-6101.2001","article-title":"The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3.","volume":"21","author":"MG Guenther","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ccr.2010.10.022","article-title":"Hdac3 is essential for the maintenance of chromatin structure and genome stability.","volume":"18","author":"S Bhaskara","journal-title":"Cancer Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1172\/JCI35847","article-title":"Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice.","volume":"118","author":"RL Montgomery","year":"2008","journal-title":"J Clin Invest"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1128\/MCB.23.19.6993-7004.2003","article-title":"Autoregulation of mouse histone deacetylase 1 expression.","volume":"23","author":"B Schuettengruber","year":"2003","journal-title":"Mol Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.0737363100","article-title":"Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway.","volume":"100","author":"H Ryu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","article-title":"New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins.","volume":"56","author":"J Ko","year":"2001","journal-title":"Brain Res Bull"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/hmg\/10.21.2425","article-title":"Centrosome disorganization in fibroblast cultures derived from R6\/2 Huntington&apos;s disease (HD) transgenic mice and HD patients.","volume":"10","author":"K Sathasivam","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.chembiol.2009.07.010","article-title":"Chemical probes identify a role for histone deacetylase 3 in Friedreich&apos;s ataxia gene silencing.","volume":"16","author":"C Xu","year":"2009","journal-title":"Chem Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1523\/JNEUROSCI.5052-10.2011","article-title":"HDAC3 is a critical negative regulator of long-term memory formation.","volume":"31","author":"SC McQuown","journal-title":"J Neurosci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1523\/JNEUROSCI.5704-10.2011","article-title":"Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta.","volume":"31","author":"FH Bardai","journal-title":"J Neurosci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrm2346","article-title":"The Rpd3\/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men.","volume":"9","author":"XJ Yang","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e21056","DOI":"10.1371\/journal.pone.0021056","article-title":"In cortical neurons HDAC3 activity suppresses RD4-dependent SMRT export.","volume":"6","author":"FX Soriano","year":"2011","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse.","volume":"61","author":"E Hockly","year":"2003","journal-title":"Brain Res Bull"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.nbd.2005.07.007","article-title":"Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington&apos;s disease.","volume":"21","author":"E Hockly","year":"2006","journal-title":"Neurobiol Dis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-3-17","article-title":"Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington&apos;s disease.","volume":"3","author":"CL Benn","year":"2008","journal-title":"Mol Neurodegener"},{"key":"ref49","article-title":"SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington&apos;s disease.","author":"M Mielcarek","year":"2011","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0031080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T10:32:34Z","timestamp":1561285954000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0031080"}},"subtitle":[],"editor":[{"given":"Xiao-Jiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,8]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0031080","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,8]]}}}